In Review: Senate Bill 2804, S.D. 1, vertical integration, is positioned as a safeguard during significant market realignment, specifically the proposed “One Health Hawaii” partnership between HMSA and Hawaii Pacific Health. The bill would prohibit acquiring or holding stocks or other interests if the transaction lessens access to health care or increases insurance rates, amending Hawaii’s antitrust statute (HRS §480-7) to add these new standards. While intended to address a specific plan–provider transaction, the statutory language is broader and could apply across the health care marketplace. The Department of Commerce and Consumer Affairs raised concerns about regulatory overlap and uncertainty, noting that insurance rates are already subject to review under the Insurance Code and that courts could be asked to second-guess rate determinations in Chapter 480 litigation. The Department also flagged the difficulty of attributing future premium changes to a single acquisition, given the range of actuarial and economic factors that drive rates. HMSA similarly cautioned that regulating outcomes such as access levels or premium impacts may limit regulator flexibility and create unintended consequences for market stability. The bill passed unanimously out of the Senate Committee on Health and Human Services. It has not yet been scheduled for its second committee hearing in the House Committee on Consumer Protection & Commerce.

If you have any questions, please contact Tonia Sorrell-Neal at tsorrell-neal@pcmanet.org.